Synthetic biology’s uncertain regulatory future in the wake of Loper Bright Enterprises v. Raimondo

Nature Biotechnology, Published online: 22 April 2026; doi:10.1038/s41587-026-03114-3

The US Supreme Court’s decision in Loper Bright Enterprises v. Raimondo, along with federal spending cuts, may limit the potential of synthetic biology to provide innovative solutions for environmental challenges, medicine and biomanufacturing.